Cargando…
High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is malignancies of the biliary duct system and constitutes approximately 10%-20% of all primary liver cancers. Tumor mutation burden (TMB) is a useful biomarker across many cancer types for the identification of patients who will benefit from immunot...
Autores principales: | Song, Jian-Ping, Liu, Xue-Zhi, Chen, Qian, Liu, Yan-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790456/ https://www.ncbi.nlm.nih.gov/pubmed/35127895 http://dx.doi.org/10.12998/wjcc.v10.i3.790 |
Ejemplares similares
-
Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2022) -
Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus
por: Zhang, Yue, et al.
Publicado: (2019) -
Segmental intrahepatic cholestasis as a technical complication of the transjugular intrahepatic porto-systemic shunt
por: Bucher, Julian Nikolaus, et al.
Publicado: (2019) -
Prognosis after splenectomy plus pericardial devascularization vs transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding
por: Qi, Wei-Li, et al.
Publicado: (2023) -
Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)